GL1X · GenesisL1 explorer

Research workbench

Halk in complex with 1-[(1R,2R)-1-(2,4-difluorophenyl)-2-[2-(5-methyl- 1H-pyrazol-3-yl)-4-(TRIFLUOROMETHYL)PHENOXY]CYCLOPROPYL]METHANAMINE

Analyse Halk in complex with 1-[(1R,2R)-1-(2,4-difluorophenyl)-2-[2-(5-methyl… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7JYR
Type
protein
Length
287 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ALK tyrosine kinase receptor
EC
2.7.10.1
UniProt
Q9UM73
Ligands
VTA
Pockets
2 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AALK tyrosine kinase receptor (EC 2.7.10.1)protein28742% helix, 17% strandQ9UM73

Ligands and binding sites

  • VTA · 4-{[(1R,2R)-2-(2,4-difluorophenyl)cyclopropyl]oxy}-3-(5-methyl-1H-pyrazol-3-yl)benzonitrile · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14360.670.7953VTA
2600.310.7515EDO

Compared structures

  • 7JYR · hALK in complex with 1-[(1R,2R)-1-(2,4-difluorophenyl)-2-[2-(5-methyl-1H-pyrazol-3-yl)-4-(… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UM73 · AlphaFold monomer V2.0 prediction for ALK tyrosine kinase receptor (Q9UM73) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.